164 related articles for article (PubMed ID: 25358857)
1. Effect of BioAggregate on osteoclast differentiation and inflammatory bone resorption in vivo.
Zhang J; Zhu L; Peng B
Int Endod J; 2015 Nov; 48(11):1077-85. PubMed ID: 25358857
[TBL] [Abstract][Full Text] [Related]
2. Effect of BioAggregate on Receptor Activator of Nuclear Factor-Kappa B Ligand-induced Osteoclastogenesis from Murine Macrophage Cell Line In Vitro.
Zhang J; Zhu L; Yan P; Peng B
J Endod; 2015 Aug; 41(8):1265-71. PubMed ID: 25975181
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of BioAggregate and ProRoot MTA on adhesion, migration, and attachment of human dental pulp cells.
Zhu L; Yang J; Zhang J; Peng B
J Endod; 2014 Aug; 40(8):1118-23. PubMed ID: 25069918
[TBL] [Abstract][Full Text] [Related]
4. Effect of Biodentine and Bioaggregate on odontoblastic differentiation via mitogen-activated protein kinase pathway in human dental pulp cells.
Jung JY; Woo SM; Lee BN; Koh JT; Nör JE; Hwang YC
Int Endod J; 2015 Feb; 48(2):177-84. PubMed ID: 24738842
[TBL] [Abstract][Full Text] [Related]
5. Effects of 3 endodontic bioactive cements on osteogenic differentiation in mesenchymal stem cells.
Lee BN; Lee KN; Koh JT; Min KS; Chang HS; Hwang IN; Hwang YC; Oh WM
J Endod; 2014 Aug; 40(8):1217-22. PubMed ID: 25069936
[TBL] [Abstract][Full Text] [Related]
6. Anti-osteoclastogenesis of Mineral Trioxide Aggregate through Inhibition of the Autophagic Pathway.
Cheng X; Zhu L; Zhang J; Yu J; Liu S; Lv F; Lin Y; Liu G; Peng B
J Endod; 2017 May; 43(5):766-773. PubMed ID: 28292604
[TBL] [Abstract][Full Text] [Related]
7. Bioaggregate Inhibits Osteoclast Differentiation, Fusion, and Bone Resorption In Vitro.
Tian J; Qi W; Zhang Y; Glogauer M; Wang Y; Lai Z; Jiang H
J Endod; 2015 Sep; 41(9):1500-6. PubMed ID: 26233260
[TBL] [Abstract][Full Text] [Related]
8. Mineral trioxide aggregate (MTA) inhibits osteoclastogenesis and osteoclast activation through calcium and aluminum activities.
Rezende TMB; Ribeiro Sobrinho AP; Vieira LQ; Sousa MGDC; Kawai T
Clin Oral Investig; 2021 Apr; 25(4):1805-1814. PubMed ID: 32789653
[TBL] [Abstract][Full Text] [Related]
9. Mineral trioxide aggregate inhibits osteoclastic bone resorption.
Hashiguchi D; Fukushima H; Yasuda H; Masuda W; Tomikawa M; Morikawa K; Maki K; Jimi E
J Dent Res; 2011 Jul; 90(7):912-7. PubMed ID: 21531916
[TBL] [Abstract][Full Text] [Related]
10. Effects of ProRoot MTA, Bioaggregate, and Micromega MTA on odontoblastic differentiation in human dental pulp cells.
Chang SW; Lee SY; Kum KY; Kim EC
J Endod; 2014 Jan; 40(1):113-8. PubMed ID: 24332001
[TBL] [Abstract][Full Text] [Related]
11. Effect of ProRoot MTA® and Biodentine® on osteoclastic differentiation and activity of mouse bone marrow macrophages.
Kim M; Kim S; Ko H; Song M
J Appl Oral Sci; 2019 Jan; 27():e20180150. PubMed ID: 30624466
[TBL] [Abstract][Full Text] [Related]
12. Mineral trioxide aggregate solution inhibits osteoclast differentiation through the maintenance of osteoprotegerin expression in osteoblasts.
Hashiguchi D; Fukushima H; Nakamura M; Morikawa K; Yasuda H; Udagawa N; Maki K; Jimi E
J Biomed Mater Res A; 2011 Feb; 96(2):358-64. PubMed ID: 21171155
[TBL] [Abstract][Full Text] [Related]
13. Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo.
Kim JY; Oh HM; Kwak SC; Cheon YH; Lee MS; Rho MC; Oh J
Biol Pharm Bull; 2015; 38(1):66-74. PubMed ID: 25744460
[TBL] [Abstract][Full Text] [Related]
14. Effect of bioaggregate on differentiation of human periodontal ligament fibroblasts.
Yan P; Yuan Z; Jiang H; Peng B; Bian Z
Int Endod J; 2010 Dec; 43(12):1116-21. PubMed ID: 20812946
[TBL] [Abstract][Full Text] [Related]
15. Antiosteoclastogenic activity of silicate-based materials antagonizing receptor activator for nuclear factor kappaB ligand-induced osteoclast differentiation of murine marcophages.
Hung CJ; Kao CT; Chen YJ; Shie MY; Huang TH
J Endod; 2013 Dec; 39(12):1557-61. PubMed ID: 24238446
[TBL] [Abstract][Full Text] [Related]
16. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of in vitro antimicrobial activities of bioaggregate and mineral trioxide aggregate].
Cavdar Tetik EA; Dartar Öztan M; Kıyan M
Mikrobiyol Bul; 2013 Jul; 47(3):523-8. PubMed ID: 23971930
[TBL] [Abstract][Full Text] [Related]
18. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors.
Strålberg F; Kassem A; Kasprzykowski F; Abrahamson M; Grubb A; Lindholm C; Lerner UH
J Leukoc Biol; 2017 May; 101(5):1233-1243. PubMed ID: 28196851
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the biocompatibility of mineral trioxide aggregate, bioaggregate, and biodentine in the subcutaneous tissue of rats.
Simsek N; Alan H; Ahmetoglu F; Taslidere E; Bulut ET; Keles A
Niger J Clin Pract; 2015; 18(6):739-43. PubMed ID: 26289510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
